DENVER--(BUSINESS WIRE)--Vista Gold Corp. (NYSE American and TSX: VGZ) (“Vista†or the “Companyâ€) is pleased to announce that its wholly-owned...
NSC to acquire U. S. Steel for $55.00 per share in an all-cash transaction representing 40% premium, providing certain and...
- Risk-based assessment for LLM and the entire system in two stages - TOKYO--(BUSINESS WIRE)--NRI SecureTechnologies, Ltd. (NRI Secure), a...
The company’s groundbreaking drug encapsulated immunoliposomes may represent a significant improvement over existing antibody drug conjugates HANGZHOU, China--(BUSINESS WIRE)--HighField Biopharmaceuticals,...
BEIJING & BARCELONA, Spain--(BUSINESS WIRE)--#ADC--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315), a global biotech company focusing on the discovery...
 PARIS--(BUSINESS WIRE)--Regulatory News: Tikehau Capital (Paris:TKO), the global alternative asset management group, and Nikko Asset Management, one of Asia’s...
The Lineup includes the world’s first 8-inch polymer wafer for AR glasses TOKYO--(BUSINESS WIRE)--Mitsui Chemicals, Inc. (Tokyo: 4183; President &...
BANGKOK--(BUSINESS WIRE)--#BELFOR--BELFOR Thailand, the local arm of the global leader in damage restoration services, is set to diversify its operations...
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced today that...
SEOUL, South Korea--(BUSINESS WIRE)--#canada--Lydia AI, a leading Canadian health AI company, is thrilled to announce its strategic collaborations with Hecto...
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases,...
Operational efficiency is defined as the ability of an organization to use its resources effectively to produce maximum output with...
NEW YORK--(BUSINESS WIRE)--#A--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action...
– PADCEV plus pembrolizumab approved based on groundbreaking EV-302 trial – – Confirmatory trial found PADCEV plus pembrolizumab nearly doubled...
LONDON--(BUSINESS WIRE)--#worldbranding--Fourth paragraph, first sentence of release dated December 8, 2023, should read: Winners from Thailand include Thai Life Insurance,...
